These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 16413875)

  • 1. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
    Janssens S; Dubois C; Bogaert J; Theunissen K; Deroose C; Desmet W; Kalantzi M; Herbots L; Sinnaeve P; Dens J; Maertens J; Rademakers F; Dymarkowski S; Gheysens O; Van Cleemput J; Bormans G; Nuyts J; Belmans A; Mortelmans L; Boogaerts M; Van de Werf F
    Lancet; 2006 Jan; 367(9505):113-21. PubMed ID: 16413875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.
    Wollert KC; Meyer GP; Lotz J; Ringes-Lichtenberg S; Lippolt P; Breidenbach C; Fichtner S; Korte T; Hornig B; Messinger D; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Lancet; 2004 Jul 10-16; 364(9429):141-8. PubMed ID: 15246726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction.
    Plewka M; Krzemińska-Pakuła M; Lipiec P; Peruga JZ; Jezewski T; Kidawa M; Wierzbowska-Drabik K; Korycka A; Robak T; Kasprzak JD
    Am J Cardiol; 2009 Nov; 104(10):1336-42. PubMed ID: 19892047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
    Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
    Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
    Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
    Hirsch A; Nijveldt R; van der Vleuten PA; Tijssen JG; van der Giessen WJ; Tio RA; Waltenberger J; ten Berg JM; Doevendans PA; Aengevaeren WR; Zwaginga JJ; Biemond BJ; van Rossum AC; Piek JJ; Zijlstra F;
    Eur Heart J; 2011 Jul; 32(14):1736-47. PubMed ID: 21148540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
    Traverse JH; Henry TD; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Forder JR; Byrne BJ; Hatzopoulos AK; Penn MS; Perin EC; Baran KW; Chambers J; Lambert C; Raveendran G; Simon DI; Vaughan DE; Simpson LM; Gee AP; Taylor DA; Cogle CR; Thomas JD; Silva GV; Jorgenson BC; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Smith DX; Baraniuk S; Piller LB; Loghin C; Aguilar D; Richman S; Zierold C; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2011 Nov; 306(19):2110-9. PubMed ID: 22084195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
    Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
    J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study.
    Beitnes JO; Gjesdal O; Lunde K; Solheim S; Edvardsen T; Arnesen H; Forfang K; Aakhus S
    Eur J Echocardiogr; 2011 Feb; 12(2):98-106. PubMed ID: 20851818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial.
    Schaefer A; Meyer GP; Fuchs M; Klein G; Kaplan M; Wollert KC; Drexler H
    Eur Heart J; 2006 Apr; 27(8):929-35. PubMed ID: 16510465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of intracoronary delivery of mononuclear bone marrow cells in patients with myocardial infarction: a two year follow-up results.
    Plewka M; Krzemińska-Pakuła M; Peruga JZ; Lipiec P; Kurpesa M; Wierzbowska-Drabik K; Korycka-Wołowiec A; Kasprzak JD
    Kardiol Pol; 2011; 69(12):1234-40. PubMed ID: 22219096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study.
    Herbots L; D'hooge J; Eroglu E; Thijs D; Ganame J; Claus P; Dubois C; Theunissen K; Bogaert J; Dens J; Kalantzi M; Dymarkowski S; Bijnens B; Belmans A; Boogaerts M; Sutherland G; Van de Werf F; Rademakers F; Janssens S
    Eur Heart J; 2009 Mar; 30(6):662-70. PubMed ID: 19106196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of intracoronary stem cell therapy after acute myocardial infarction.
    Wöhrle J; Merkle N; Mailänder V; Nusser T; Schauwecker P; von Scheidt F; Schwarz K; Bommer M; Wiesneth M; Schrezenmeier H; Hombach V
    Am J Cardiol; 2010 Mar; 105(6):804-12. PubMed ID: 20211323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
    Traverse JH; Henry TD; Moye' LA
    Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.
    Traverse JH; Henry TD; Pepine CJ; Willerson JT; Chugh A; Yang PC; Zhao DXM; Ellis SG; Forder JR; Perin EC; Penn MS; Hatzopoulos AK; Chambers JC; Baran KW; Raveendran G; Gee AP; Taylor DA; Moyé L; Ebert RF; Simari RD
    Circ Res; 2018 Feb; 122(3):479-488. PubMed ID: 29208679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
    Traverse JH; Henry TD; Pepine CJ; Willerson JT; Zhao DX; Ellis SG; Forder JR; Anderson RD; Hatzopoulos AK; Penn MS; Perin EC; Chambers J; Baran KW; Raveendran G; Lambert C; Lerman A; Simon DI; Vaughan DE; Lai D; Gee AP; Taylor DA; Cogle CR; Thomas JD; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Kappenman C; Westbrook L; Piller LB; Simpson LM; Baraniuk S; Loghin C; Aguilar D; Richman S; Zierold C; Spoon DB; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2012 Dec; 308(22):2380-9. PubMed ID: 23129008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging.
    Ruan W; Pan CZ; Huang GQ; Li YL; Ge JB; Shu XH
    Chin Med J (Engl); 2005 Jul; 118(14):1175-81. PubMed ID: 16117862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow mesenchymal stem cells transfer in patients with ST-segment elevation myocardial infarction: single-blind, multicenter, randomized controlled trial.
    Zhang R; Yu J; Zhang N; Li W; Wang J; Cai G; Chen Y; Yang Y; Liu Z
    Stem Cell Res Ther; 2021 Jan; 12(1):33. PubMed ID: 33413636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial.
    Drexler H; Meyer GP; Wollert KC
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S65-8. PubMed ID: 16501634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.